Evidence map›Paper›PMID 40601721›Full record

ArticleScience advances2025

Toward developing a compact total artificial heart using a soft robotic fluidic transmission system.

Maziar Arfaee, Lucas C van Laake, Shibo Zou, Charlotte Bording, Jolanda Kluin, Johannes T B Overvelde

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Soft robotic devices for cardiovascular medicine.Nature reviews. Cardiology · 2026
    Review
  2. Article
  3. The Total Artificial Heart: A Historical Perspective.Journal of clinical medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maziar ArfaeeCardiothoracic Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-4459-5582
Lucas C van LaakeAutonomous Matter Department, AMOLF, Amsterdam, Netherlands.ORCID 0000-0003-1366-8969
Shibo ZouAutonomous Matter Department, AMOLF, Amsterdam, Netherlands.ORCID 0000-0002-9154-0058
Charlotte BordingAutonomous Matter Department, AMOLF, Amsterdam, Netherlands.
Jolanda KluinCardiothoracic Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-5942-4727
Johannes T B OverveldeAutonomous Matter Department, AMOLF, Amsterdam, Netherlands.ORCID 0000-0003-0253-0147

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases are a leading cause of mortality, with limited possibilities for transplantation due to a critical shortage of donor hearts. Replacing the heart with total artificial hearts (TAHs) remains challenging, due to size constraints and energy requirements, among others. To address this, we introduce the LIMO heart, a compact TAH concept based on an efficient soft fluidic transmission system. By reducing actuator volume and enhancing energy transfer, LIMO enables a more compact and efficient design. We developed a soft ventricle prototype using thin-walled pouch actuators that achieve transmission ratios above one via circumferential shrinkage. A fast, cost-effective prototyping method accelerated testing. Experimental results showed high energy transfer efficiency (82 to 91%), and in vitro tests demonstrated promising cardiac outputs of 5.9 liters per minute against aortic pressure and 7.6 liters per minute against pulmonary pressure. These findings represent a step toward a more broadly applicable biventricular soft robotic TAH for treating end-stage heart failure.

Indexed as

Heart, ArtificialRoboticsEquipment DesignHeart FailureHumans

Identifiers

PMID40601721
PMCPMC12219477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.